|2.||Renal Insufficiency (Renal Failure)
|3.||Cardiovascular Diseases (Cardiovascular Disease)
02/01/1981 - "The antiarrhythmic activity of intravenous moxaprindine was evaluated in 26 patients with cardiovascular disease; the mean maximum dose was 2.5 +/- 0.12 mg/kg. Ventricular extopics were completely abolished in 19 patients and significantly reduced in four patients, but were not favourably affected in three patients. "
02/01/1981 - "Moxaprindine in the acute treatment of ventricular arrhythmias in patients with cardiovascular disease."